Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Gökçe Yavan; Zehra Pınar Koç; Pınar Pelin Özcan

Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Abstract

Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical practice, and plays an essential role in preoperative systemic evaluation and tumor staging in various cancer patients. With this method, it is possible to measure or compare metabolic changes in cancer cells. With combined PET/CT, it is possible to determine the correct anatomical location in hypermetabolic tumors with uptake of FDG. In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT

Keywords

References

1. Sachpekidis, C., Exadaktylou, P., Katsampoukas, D., Moralidis, E., & Arsos, G. (2020). 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine, 23(1), 76–78. https://doi.org/10.1967/s002449912006
2. Zeng, W., Lechowicz, M. J., Winton, E., Cho, S. M., Galt, J. R., & Halkar, R. (2009). Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine, 34(6), 355–358. https://doi.org/10.1097/RLU.0b013e3181a34552
3. Wang, X., Chen, Z., Tang, G., & Zhang, X. (2011). A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT. Clinical nuclear medicine, 36(7), 612–615. https://doi.org/10.1097/RLU.0b013e318217af84

Details

Primary Language

English

Subjects

Oncology and Carcinogenesis

Journal Section

Case Report

Authors

Gökçe Yavan ^* This is me
0000-0002-7332-6293
Türkiye

Zehra Pınar Koç This is me
0000-0002-3274-5790
Türkiye

Pınar Pelin Özcan This is me
0000-0003-0147-2678
Türkiye

Publication Date

August 1, 2022

Submission Date

July 8, 2022

Acceptance Date

July 15, 2022

Published in Issue

Year 2022 Volume: 2 Number: 2

IZ

https://izlik.org/JA74ST68DJ

Cite

RIS / Bibtex

APA

Yavan, G., Koç, Z. P., & Özcan, P. P. (2022). Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging, 2(2), 25-26. https://izlik.org/JA74ST68DJ

AMA

1.Yavan G, Koç ZP, Özcan PP. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022;2(2):25-26. https://izlik.org/JA74ST68DJ

Chicago

Yavan, Gökçe, Zehra Pınar Koç, and Pınar Pelin Özcan. 2022. “Abdominal Mass Shown by the FDG PET CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging 2 (2): 25-26. https://izlik.org/JA74ST68DJ.

EndNote

Yavan G, Koç ZP, Özcan PP (August 1, 2022) Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging 2 2 25–26.

IEEE

[1]G. Yavan, Z. P. Koç, and P. P. Özcan, “Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma”, Molecular Oncologic Imaging, vol. 2, no. 2, pp. 25–26, Aug. 2022, [Online]. Available: https://izlik.org/JA74ST68DJ

ISNAD

Yavan, Gökçe - Koç, Zehra Pınar - Özcan, Pınar Pelin. “Abdominal Mass Shown by the FDG PET CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging 2/2 (August 1, 2022): 25-26. https://izlik.org/JA74ST68DJ.

JAMA

1.Yavan G, Koç ZP, Özcan PP. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022;2:25–26.

MLA

Yavan, Gökçe, et al. “Abdominal Mass Shown by the FDG PET CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging, vol. 2, no. 2, Aug. 2022, pp. 25-26, https://izlik.org/JA74ST68DJ.

Vancouver

1.Gökçe Yavan, Zehra Pınar Koç, Pınar Pelin Özcan. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging [Internet]. 2022 Aug. 1;2(2):25-6. Available from: https://izlik.org/JA74ST68DJ